Chemed Corporation (CHE) vs Rhythm Pharmaceuticals, Inc. (RYTM)
A side-by-side comparison of Chemed Corporation and Rhythm Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CHE
Chemed Corporation
$509.52HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
RYTM
Rhythm Pharmaceuticals, Inc.
$90.92HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — CHE vs RYTM
growth of $100 · dividends reinvested · last 9yCHE +158.2% (+11.1%/yr)RYTM +208.2% (+13.3%/yr)RYTM compounded faster over this window
CHE RYTM
CHE vs RYTM: by the numbers
- •CHE is the larger company ($6.66B vs $6.24B market cap).
- •CHE is profitable (10.60% net margin) while RYTM runs a net loss (-85.59%).
- •RYTM grew revenue faster over the past five years (278.53% vs 4.12% CAGR).
- •CHE pays a dividend (0.49% yield), while RYTM has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CHE | RYTM |
|---|---|---|
| P/E ratio | 25.58 | N/A |
| Forward P/E | 19.99 | N/A |
| P/S ratio | 2.57 | 25.99 |
| P/B ratio | 8.02 | 60.56 |
| EV / EBITDA | 16.72 | N/A |
| FCF yield | 4.86% | N/A |
Profitability
| Metric | CHE | RYTM |
|---|---|---|
| Gross margin | 30.44% | 89.00% |
| Operating margin | 13.46% | -101.19% |
| Net margin | 10.60% | -85.59% |
| ROE | 33.11% | -94.50% |
| ROIC | 19.48% | -63.96% |
Dividends
| Metric | CHE | RYTM |
|---|---|---|
| Dividend yield | 0.49% | N/A |
| Payout ratio | 12.55% | N/A |
Growth (annualized)
| Metric | CHE | RYTM |
|---|---|---|
| Revenue CAGR (5Y) | 4.12% | 278.53% |
| EPS CAGR (5Y) | -1.65% | N/A |
| FCF CAGR (5Y) | -5.44% | N/A |
| Total return CAGR (5Y) | 3.58% | 49.95% |
Frequently asked
- Which has grown faster, CHE or RYTM?
- Over the past five years, RYTM grew revenue faster — CHE at a 4.12% CAGR versus RYTM at 278.53%.
- Does CHE or RYTM pay a bigger dividend?
- CHE pays a dividend (0.49% yield), while RYTM has no payments in the available dividend history.
- Is CHE or RYTM more profitable?
- CHE runs the higher net margin — CHE at 10.60% versus RYTM at -85.59%.
- How have CHE and RYTM total returns compared?
- Over the past 5 years, CHE delivered 3.58% and RYTM delivered 49.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Chemed P/E ratioChemed dividend yieldChemed ROERhythm Pharmaceuticals ROEChemed operating marginRhythm Pharmaceuticals operating marginChemed revenue growthRhythm Pharmaceuticals revenue growthChemed free cash flowRhythm Pharmaceuticals free cash flow
Chemed & Rhythm Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.